Prognostic significance of heat shock proteins in urothelial carcinoma of the urinary bladder

Histopathology

Volumn 62, Issue 5, 2013, Pages 788-798

  Yu, Hui Jung ^a   Chang, Yen Hwa ^b   Pan, Chin Chen ^c  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Heat shock protein; Prognosis; Urinary bladder; Urothelial carcinoma

Indexed keywords

CHAPERONIN 60; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; TAIWAN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM; YOUNG ADULT;

EID: 84875581237     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12087     Document Type: Article

References (31)

1. Lopes-Beltran A, Sauter G, Gasser T et al. Tumours of the urinary system. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press, 2004; 89-123.
2. Pan CC, Chang YH, Chen KK, Yu HJ, Sun CH, Ho DM. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1, 515 cases. Am. J. Clin. Pathol. 2010; 133; 788-795.
3. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992; 355; 33-34.
4. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl Cancer Inst. 2000; 92; 1564-1572.
5. Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 1993; 259; 1409-1410.
6. Jaattela M. Escaping cell death: survival proteins in cancer. Exp. Cell Res. 1999; 248; 30-43.
7. Srivastava PK. Heat shock proteins in immune response to cancer: the Fourth Paradigm. Experientia 1994; 50; 1054-1060.
8. Wells AD, Malkovsky M. Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol. Today 2000; 21; 129-132.
9. Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J. Innate Immun. 2010; 2; 238-247.
10. Cornford PA, Dodson AR, Parsons KF et al. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res. 2000; 60; 7099-7105.
11. Devaja O, King RJ, Papadopoulos A, Raju KS. Heat-shock protein 27 (HSP27) and its role in female reproductive organs. Eur. J. Gynaecol. Oncol. 1997; 18; 16-22.
12. Geisler JP, Geisler HE, Tammela J, Miller GA, Wiemann MC, Zhou Z. A study of heat shock protein 27 in endometrial carcinoma. Gynecol. Oncol. 1999; 72; 347-350.
13. Kawanishi K, Shiozaki H, Doki Y et al. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 1999; 85; 1649-1657.
14. King KL, Li AF, Chau GY et al. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 2000; 88; 2464-2470.
15. Nakajima M, Kuwano H, Miyazaki T, Masuda N, Kato H. Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett. 2002; 178; 99-106.
16. Santarosa M, Favaro D, Quaia M, Galligioni E. Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients. Eur. J. Cancer 1997; 33; 873-877.
17. Tetu B, Lacasse B, Bouchard HL, Lagace R, Huot J, Landry J. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study. Cancer Res. 1992; 52; 2325-2328.
18. Aghdassi A, Phillips P, Dudeja V et al. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res. 2007; 67; 616-625.
19. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005; 10; 86-103.
20. Lebret T, Watson RW, Fitzpatrick JM. Heat shock proteins: their role in urological tumors. J. Urol. 2003; 169; 338-346.
21. Wang XY, Kaneko Y, Repasky E, Subjeck JR. Heat shock proteins and cancer immunotherapy. Immunol. Invest. 2000; 29; 131-137.
22. Cappello F, David S, Ardizzone N et al. Expression of heat shock prteins HSP10, HSP27, HSP60, HSP70, and HSP90 in urothelial carcinoma of urinary bladder. J. Cancer Mol. 2006; 2; 73-77.
23. Cardillo MR, Sale P, Di SF. Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res. 2000; 20; 4579-4583.
24. Lebret T, Watson RW, Molinie V et al. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer 2003; 98; 970-977.
25. Storm FK, Mahvi DM, Gilchrist KW. Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers. Urology 1993; 42; 379-382.
26. Syrigos KN, Harrington KJ, Karayiannakis AJ et al. Clinical significance of heat shock protein-70 expression in bladder cancer. Urology 2003; 61; 677-680.
27. Pan CC, Chen PC, Chiang H. An easy method for manual construction of high-density tissue arrays. Appl. Immunohistochem. Mol. Morphol. 2004; 12; 370-372.
28. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 1999; 94; 496-509.
29. Wolbers M, Koller MT, Witteman JC, Steyerberg EW. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 2009; 20; 555-561.
30. Altman DG. Misleading interpretation of results from a small study. Urology 1994; 43; 411-412.
31. Philips J, Temple J, Javle P et al. Phenotypic and genotypic analysis of neoplastic lesions of the urinary bladder. In Foster CS, Ross JS eds. Pathology of the urinary bladder. Major problems in pathology. Philadelphia, PA: Saunders, 2004; 258-259.